[Severe Acute Respiratory Syndrome Epidemics: the End or a Hiatus of the Epidemic?]
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Recent progress in the discovery of inhibitors targeting coronavirus proteases.
Wang H, Xue S, Yang H, Chen C Virol Sin. 2016; 31(1):24-30.
PMID: 26920707 PMC: 7090653. DOI: 10.1007/s12250-015-3711-3.
[Severe acute respiratory syndrome: will it come back?].
Vaque J, Calico I Med Clin (Barc). 2003; 121(18):700-2.
PMID: 14651819 PMC: 7131240. DOI: 10.1016/s0025-7753(03)74068-8.
References
1.
Phillips J, Chua M, Lavi E, Weiss S
. Pathogenesis of chimeric MHV4/MHV-A59 recombinant viruses: the murine coronavirus spike protein is a major determinant of neurovirulence. J Virol. 1999; 73(9):7752-60.
PMC: 104302.
DOI: 10.1128/JVI.73.9.7752-7760.1999.
View
2.
Salleras L
. [Severe Acute Respiratory Syndrome. A new emergent infectious disease]. Med Clin (Barc). 2003; 120(16):619-21.
PMC: 7130704.
DOI: 10.1016/s0025-7753(03)73789-0.
View
3.
Poutanen S, Low D, Henry B, Finkelstein S, Rose D, Green K
. Identification of severe acute respiratory syndrome in Canada. N Engl J Med. 2003; 348(20):1995-2005.
DOI: 10.1056/NEJMoa030634.
View
4.
Hon K, Leung C, Cheng W, Chan P, Chu W, Kwan Y
. Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet. 2003; 361(9370):1701-3.
PMC: 7112484.
DOI: 10.1016/s0140-6736(03)13364-8.
View
5.
. SARS outbreak in the Philippines. Wkly Epidemiol Rec. 2003; 78(22):189-92.
View